Everspin Technologies to Present at the Baird Virtual Vehicle Technology & Mobility Conference
Everspin Technologies Inc., (NASDAQ: MRAM), the market leader in MRAM, announced that Sanjeev Aggarwal, President and Chief Executive Officer and Anuj Aggarwal, Chief Financial Officer, will present at the Baird virtual Vehicle Technology & Mobility Conference, on February 29th at 1:05 p.m. Eastern Time.
A live webcast, as well as a replay, of the presentation will be available on the company's investor relations website at https://www.everspin.com/.
About Everspin Technologies
Everspin Technologies, Inc. is the world's leading provider of Magnetoresistive RAM (MRAM). Everspin MRAM delivers the industry's most robust, highest performance non-volatile memory for Industrial IoT, Data Center, and other mission-critical applications where data persistence is paramount. Headquartered in Chandler, Arizona, Everspin provides commercially available MRAM solutions to a large and diverse customer base. For more information, visit www.everspin.com. NASDAQ: MRAM.
Husqvarna Group, a global leader in outdoor power products, has successfully halved its absolute CO2 emissions compared to the 2015 baseline year. A significant milestone achieved at the same time as the business's sales has increased by 47 percent....
MetaComp Pte Ltd, a leading Monetary Authority of Singapore (MAS) licensed Singapore fintech company that specializes in blockchain technology and digital assets, and its affiliates (collectively referred as MetaComp), is proud to announce a...
Elliptic Labs (OSE: ELABS), a global AI software company and the world leader in AI Virtual Smart Sensorstm currently deployed in over 500 million devices, is shipping its AI Virtual Proximity Sensortm INNER BEAUTY® on the newly announced Moondrop...
April 29, 2024 First-quarter highlights Group sales amounted to EUR 4.1 billion, with comparable sales growth of 2.4%Comparable order intake -3.8%, mainly due to ChinaUSD 1.1 billion Respironics litigation settlement reached in the US...
4P-Pharma, a Lille-based clinical-stage startup studio focused on developing curative therapies for untreated serious diseases, announces that it has successfully secured a total capital of ?15 million in its second closing with participation from...
